KEY POINTS Yescarta is the US FDA approved second CAR T-cell based gene therapy. Here are the 8 interesting facts ...
Gilead Sciences’ once-daily single tablet regimen (STR), Biktarvy® received the US FDA approval for the treatment of HIV-1 infection in ...
KEY POINTS YL Biologics announced the successful clinical outcome of YLB113- biosimilar version of Amgen’s blockbuster rheumatoid arthritis drug, Enbrel® ...
KEY POINTS The new drug approved by FDA targets hard-to-treat, a rare form of pancreatic cancer. It is the same ...
KEY POINTS The newly approved arsenic therapy treats low risk acute promyelocytic leukemia patients. Trisenox is currently being evaluated for ...
KEY POINTS Takeda’s inactivated, whole Zika virus vaccine candidate- TAK-426 (PIZV) received ‘fast track’ status The initial ZIK-101 study results ...
KEY POINTS New treatment option- anti-CGRP drugs, to prevent a migraine is expected to reach the market in 2018. Allergan’s ...